Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

What are bath salts and why are they dangerous?

Roy Michael Stefanik, DO
Meds
July 5, 2012
117 Shares
Share
Tweet
Share

Bath salts are a relatively new group of designer drugs sold as tablets, capsules, or powder and purchased in places such as tobacco and convenience stores, gas stations, head shops, and the Internet.

They are stimulants that mimic cocaine, lysergic acid diethylamide (LSD), methamphetamine, or methylenedioxymethamphetamine (ecstasy). According to a recent article in the Journal of Psychosocial Nursing, the most common bath salts are MDPV, mephedrone, and methylone. These drugs cause intense stimulation, euphoria, elevated mood, and a reportedly pleasurable “rush.” Increased heart rate and blood pressure, chest pain, hallucinations, paranoia, erratic behavior, inattention, lack of memory of substance use, and psychosis have been observed in those who have used bath salts.

The U.S. Drug Enforcement Administration recently exercised an emergency authority to name three key ingredients in bath salts as Schedule I, thereby making them illegal to possess or sell in the United States. Part of the appeal of using bath salts is the current difficulty in picking up its use on routine drug screens.

MDPV is a phenethylamine and a norepinephrine-dopamine reuptake inhibitor. It is a central nervous system (CNS) stimulant with hallucinogenic effects. A similar form of the drug, pyrovalerone, was developed in the 1960’s in the US to treat chronic fatigue syndrome but was rejected due to problems with abuse and dependency. Oral, nasal, sublingual, rectal, intravenous, and intramuscular use have been reported. A dose usually has an effect of about 2 to 3 hours. Users reportedly experience feelings of stimulation, euphoria, empathy, and being more aware of their senses. Physical manifestations include an increase in blood pressure, heart rate, and sweating. More distressing side effects include prolonged and intense panic attacks as well as psychosis, which may last up to 8 hours after use. There is a high risk of toxicity, dependence, and withdrawal.

Mephedrone is also in the phenethylamine category and is a CNS stimulant that can cause hallucinations and agitation. Users will ingest the capsules, dissolve it in water, snort it, or use it rectally (known as bombing). Effects begin within 45 minutes of use. Side effects include nausea, rapid heart rate, increased blood pressure, chest pain, irritability, dizziness, nosebleeds, and delusions. It has also been associated with impaired impulse control and violent behavior.

Methylone is a stimulant in the phenethylamine class with properties very similar to ecstasy. It is a reuptake inhibitor of serotonin, norepinephrine, and dopamine. After oral, nasal, or rectal use, effects occur within 20 minutes and last about 2 hours. Users report euphoria, a sense of well-being, and increased perception of sensory stimuli. It can cause a racing heart, elevated temperature, pupil dilation, jaw clenching, dizziness, nausea, confusion, and paranoia. Both this and mephedrone have been found to be highly addictive.

Bath salts have been packaged and labeled as “plant food” or “not for human consumption,” and product labels do not list the ingredients. Names include Vanilla Sky, Ivory Wave, plant fertilizer, Cloud 9, m-CAT, Mad Cow, and M1. The Internet is replete with stories of its use, including out-of-control violence, hallucinations, and even sensationalized reports of cannibalism and murder/suicide. Treatment usually starts with Ativan, followed by the use of antipsychotics such as Risperdal or Haldol if unresponsive to Ativan.

Its recent surge represents a disturbing trend in the use of these drugs associated with violent acts. States are trying to pass individual laws to prohibit its use. Creating standardized methods of identification in users is necessary to create an effective means of stopping or controlling its distribution, and hopefully providing treatment for those unfortunate enough to experience its effects.

Roy Michael Stefanik is a psychiatrist who blogs at Fairfax Mental Health.

Prev

The functional and professional necessity of detachment

July 5, 2012 Kevin 7
…
Next

Requiring ID to buy Plan B is ludicrous

July 6, 2012 Kevin 3
…

Tagged as: Medications, Psychiatry

Post navigation

< Previous Post
The functional and professional necessity of detachment
Next Post >
Requiring ID to buy Plan B is ludicrous

More by Roy Michael Stefanik, DO

  • a desk with keyboard and ipad with the kevinmd logo

    The difference between a child psychologist and child psychiatrist

    Roy Michael Stefanik, DO

More in Meds

  • Levamisole is good for your dog, but bad for your cocaine

    Robert Killeen, MD
  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • Most Popular

  • Past Week

    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • End-of-life ethics and antibiotic use [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
  • Recent Posts

    • End-of-life ethics and antibiotic use [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician return-to-work policies

      Deepak Gupta, MD | Physician
    • Communication, power dynamics, and organizational culture in health care

      Beth Boynton, RN, MS, CP | Conditions
    • How my patients’ Zoom backgrounds made me a better doctor

      Joseph Barrera, MD | Physician
    • Understanding reproductive rights: complex considerations

      Anonymous | Physician
    • Innovations in surgical education [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Mortality Risk From Damaged Bronchi Extends to People Without COPD
  • ChatGPT Improving, but Still Lacks Reliability as a Clinical Support Tool
  • COVID Vax in Pregnancy Protects Young Infants Against Omicron
  • Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure
  • FDA OKs Another Injectable for Rare Kidney Disorder

Meeting Coverage

  • Hot Flashes: Precursor to Alzheimer's Disease?
  • SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer
  • Menopausal Women With Obesity Endure Worse Symptoms, Less HT Relief
  • Study Pinpoints Growing Use of Cannabis to Manage Menopause Symptoms
  • Fezolinetant Benefits Women Not Suited for Hormone Therapy
  • Most Popular

  • Past Week

    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • End-of-life ethics and antibiotic use [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
  • Recent Posts

    • End-of-life ethics and antibiotic use [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician return-to-work policies

      Deepak Gupta, MD | Physician
    • Communication, power dynamics, and organizational culture in health care

      Beth Boynton, RN, MS, CP | Conditions
    • How my patients’ Zoom backgrounds made me a better doctor

      Joseph Barrera, MD | Physician
    • Understanding reproductive rights: complex considerations

      Anonymous | Physician
    • Innovations in surgical education [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What are bath salts and why are they dangerous?
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...